The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
TP53 mutation in colorectal cancer
Open accessAbstract
Approximately half of all colorectal cancers show p53 (TP53) gene mutations, with higher frequencies observed in distal colon and rectal tumors and lower frequencies in proximal tumors and those with the microsatellite instability or methylator phenotypes. Alterations to this gene appear to have little or no prognostic value for colorectal cancer patients treated by surgery alone, but are associated with worse survival for patients treated with chemotherapy. There is some evidence that different p53 mutations are associated with different clinical features including prognosis and response to therapy, although further large studies are required to confirm this. Several in vitro, animal and clinical studies have shown that normal p53 is required for the response of colorectal cancers to 5-fluorouracil-based chemotherapy. This should be confirmed by additional retrospective cohort studies and by the incorporation of P53 status in ongoing and future clinical trials. The evaluation of p53 overexpression, using a standardized immunohistochemical (IHC) procedure, could be a clinically useful marker for the identification of colorectal cancer patients likely to benefit from the standard chemotherapy regime currently used for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044
p53 mutations in colorectal cancer.
Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J. V., & Lane, D. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7555 · Cited by 1,003
Kirsten ras mutations in patients with colorectal cancer: The multicenter “RASCAL” study
Andreyev, H. J. N., Norman, A. R., Clarke, P. A., Cunningham, D., & Oates, J. R. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.675 · Cited by 748
Baas, I. O., Mulder, J. R., Offerhaus, G. J. A., Vogelstein, B., & Hamilton, S. R. (1994) · The Journal of Pathology · doi:10.1002/path.1711720104 · Cited by 505
A simple p53 functional assay for screening cell lines, blood, and tumors.
Flaman, J. M., Frebourg, T., Moreau, V, Charbonnier, F., Martin, C., Chappuis, P., Sappino, A. P., Limacher, I. M., Bron, L., & Benhattar, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3963 · Cited by 454
Ahnen, D. J., Feigl, P., Quan, G., Fenoglio‐Preiser, C. M., Lovato, L., Bunn, P. A., Stemmerman, G. N., Wells, J. D., Macdonald, J. S., & Meyskens, F. L. (1998) · PubMed · Cited by 338
MULTIPLE GENETIC ALTERATIONS IN DISTAL AND PROXIMAL COLORECTAL CANCER
Delattre, O., Law, D. J., Remvikos, Y., Sastre, X., Feinberg, A. P., Olschwang, S., Melot, T., Salmon, R. J., Validire, P., & Thomas, G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90537-0 · Cited by 302
Soussi, T., Dehouche, K., & B�roud, C. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200001)15:1<105::aid-humu19>3.0.co;2-g · Cited by 271
Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer
Bell, S. M., Scott, N., Cross, D., Sagar, P., Lewis, F. A., Blair, G. E., Taylor, G. R., Dixon, M. F., & Quirke, P. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90835-z · Cited by 245
p53 expression in colorectal tumors.
Purdie, C. A., O’Grady, J., Piris, J., Wyllie, A. H., & Bird, C. (1991) · PubMed Central · Cited by 240
p53 point mutation and survival in colorectal cancer patients.
Goh, H. S., Yao, J. T. D., & Smith, D. R. (1995) · PubMed · Cited by 234
Prognostic significance of p53 overexpression in gastric and colorectal carcinoma
Starzynska, T., Bromley, M., Ghosh, A., & Stern, P. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.314 · Cited by 226
Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
Sun, X.-F., Carstensen, J. M., Stål, O., Wingren, S., Hatschek, T., Nordenskjöld, B., & Zhang, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)92558-w · Cited by 223
Bolis, G. (1988) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198843030-00022 · Cited by 217
Elsaleh, H., Powell, B. L., McCaul, K. A., Grieu, F., Grant, R., Joseph, D., & Iacopetta, B. J. (2001) · PubMed · Cited by 204
Self-citationThe UMD-p53 database: New mutations and analysis tools
Béroud, C., & Soussi, T. (2003) · Human Mutation · doi:10.1002/humu.10187 · Cited by 176
Prognostic significance of p53 mutations in colon cancer at the population level
Samowitz, W. S., Curtin, K., Ma, K.-N., Edwards, S. L., Schaffer, D., Leppert, M., & Slattery, M. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10405 · Cited by 136
Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas
Dix, B. R., Robbins, P. F., Carrello, S., House, A. K., & Iacopetta, B. M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.355 · Cited by 128
Self-citationPrognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma
Soong, R., Powell, B., Elsaleh, H., Gnanasampanthan, G., Smith, D. R., Goh, H. S., Joseph, D. J., & Iacopetta, B. M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00285-9 · Cited by 122
Self-citationBørresen‐Dale, A., Lothe, R. A., Meling, G. I., Hainaut, P. L., Rognum, T. O., & Skovlund, E. (1998) · PubMed · Cited by 119
Prognostic Value of p53 Genetic Changes in Colorectal Cancer
Kressner, U., Inganäs, M., Byding, S., Blikstad, I., Påhlman, L., Glimelius, B. L. G., & Lindmark, G. E. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.593 · Cited by 111
Soussi, T., & Béroud, C. (2003) · Human Mutation · doi:10.1002/humu.10189 · Cited by 103
p53 alterations are associated with improved prognosis in distal colonic carcinomas.
Soong, R., Grieu, F., Robbins, P., Dix, B. R., Chen, D., Parsons, R. E., House, A. K., & Iacopetta, B. M. (1997) · PubMed · Cited by 101
Self-citationLiang, J., Huang, K., Cheng, Y., Hsu, H., Cheng, A., Hsu, C., Yeh, K., Wang, S., & Chang, K. (2001) · International Journal of Cancer · doi:10.1002/ijc.1637 · Cited by 73
p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer?
Poller, D. N., Baxter, K. J., & Shepherd, N. A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.14 · Cited by 72
Hamelin, R., Jego, N., Laurent‐Puig, P., Vidaud, M., & Thomas, G. D. (1993) · PubMed · Cited by 70
Tollenaar, R., van Krieken, J., van Slooten, H.-J., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.306 · Cited by 68
Detection of p53 Mutations by Single-strand Conformation Polymorphisms (SSCP) Gel Electrophoresis
Bòsari, S., Marchetti, A., Buttitta, F., et al. (1995) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199512000-00004 · Cited by 63
Expression of high p53 levels in colorectal cancer: a favourable prognostic factor
Adrover, E., Maestro, M. L., Casla, M. T. S., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690660 · Cited by 38
Conserved region mutations of the p53 gene are concentrated in distal colorectal cancers
Jernvall, P., Mäkinen, M. J., Karttunen, T. J., Mäkelä, J. T., & Vihko, P. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970220)74:1<97::aid-ijc17>3.0.co;2-f · Cited by 31
Diez, M., Medrano, M., Mugüerza, J. M., Ramos, P., Hernandez, P., Villeta, R., Martín, A., Noguerales, F., Ruiz, A., & Granell, J. (2001) · PubMed · Cited by 30
p53 Exon 7 mutations as a predictor of poor prognosis in patients with colorectal cancer
Iniesta, P., Vega, F. J. P., Caldés, T., et al. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00138-4 · Cited by 26
Cited by
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
SIGNALING PATHWAYS IN INTESTINAL DEVELOPMENT AND CANCER
Sancho, E., Batlle, E., & Clevers, H. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.092805 · Cited by 532
Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer
Carethers, J. M., & Jung, B. H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.047 · Cited by 483
p53: 25 years after its discovery
Hofseth, L. J., Hussain, S. P., & Harris, C. C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.009 · Cited by 431
Metadata
- Authors
- Iacopetta, B.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2003-02-27
- Volume
- 21
- Issue
- 3
- Pages
- 271-276
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W2088010622
- Cited by
- 345
- References
- 34
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.